Bicara Therapeutics Share Price Today: Live Updates & Key Insights

Bicara Therapeutics share price today is $18.43, up -2.02%. The stock opened at $18.71 against the previous close of $18.79, with an intraday high of $19.44 and low of $17.94.

Bicara Therapeutics Share Price Chart

Bicara Therapeutics

us-stock
To Invest in {{usstockname}}
us-stock

Bicara Therapeutics Share Price Performance

$18.43 -0.0202(-2.02%) BCAX at 23 Mar 2026 12:10 PM Biotechnology
Lowest Today 17.94
Highest Today 19.44
Today’s Open 18.71
Prev. Close 18.79
52 Week High 20.25
52 Week Low 7.80
Day’s Range: Low 17.94 High 19.44
52-Week Range: Low 7.80 High 20.25
1 day return -
1 Week return -5.0
1 month return +12.48
3 month return +0.21
6 month return +71.44
1 year return +33.16
3 year return -
5 year return -
10 year return -

Bicara Therapeutics Institutional Holdings

Bicara Therapeutics Market Status

Strong Buy: 4

Buy: 2

Hold: 1

Sell: 0

Strong Sell: 0

Bicara Therapeutics Fundamentals

Market Cap 1192.93 M

PB Ratio 3.0213

PE Ratio 3.4219

Enterprise Value 929.36 M

Total Assets 569.20 M

Volume 1190899

Bicara Therapeutics Company Financials

About Bicara Therapeutics & investment objective

Company Information Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody with a domain that binds to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.

Organisation Biotechnology

Employees 55

Industry Biotechnology

CEO Dr. Claire Mazumdar Clemon M.B.A., Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Bicara Therapeutics FAQs

What is the share price of Bicara Therapeutics today?

The current share price of Bicara Therapeutics is $18.43.

Can I buy Bicara Therapeutics shares in India?

Yes, Indian investors can buy Bicara Therapeutics shares by opening an international trading and demat account with Motilal Oswal.

How to buy Bicara Therapeutics shares in India?

You can easily invest in Bicara Therapeutics shares from India by:

Can I buy fractional shares of Bicara Therapeutics?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Bicara Therapeutics?

Bicara Therapeutics has a market cap of $1192.93 M.

In which sector does Bicara Therapeutics belong?

Bicara Therapeutics operates in the Biotechnology sector.

What documents are required to invest in Bicara Therapeutics stocks?

To invest, you typically need:

What is the PE and PB ratio of Bicara Therapeutics?

The PE ratio of Bicara Therapeutics is 3.42 and the PB ratio is 3.02.